Hormone symptoms in women: what people arrive with

Sleep goes first for many women, and often it is not difficulty falling asleep but waking at three in the morning, sometimes hot, and lying there. Everything downstream of sleep then deteriorates, which is why people so often present with the consequences rather than the cause.

Temperature symptoms are the ones with a name attached, and their range surprises people. Not everyone has dramatic hot flushes. Many describe a low-grade constant warmth, night sweats that are only noticed as damp sheets, or a new inability to tolerate being slightly too warm.

Mood change is frequently the symptom that brings someone in, because it is the one affecting other people. Irritability out of proportion, a shorter fuse, anxiety that is new, or a flatness that is not quite depression but is not normal either.

Then the cognitive complaints: word-finding, losing the thread mid-sentence, walking into rooms. These are distressing in a specific way, because people quietly fear they signal something worse.

And the physical ones people mention last or not at all: joint aches, changes in libido, vaginal dryness, discomfort with sex, urinary changes, skin and hair changes. These are common, they are treatable, and they go unmentioned because nobody asked.

Menopause is a single point, defined retrospectively as twelve months after the final period. Perimenopause is the transition before it, and it commonly runs for several years.

During perimenopause hormone levels fluctuate rather than simply declining. That fluctuation is why symptoms come and go, why they can be severe in a month when the cycle still looks normal, and why a single blood test on a single day can be an unreliable guide.

This is also why women are so often told their bloodwork is normal and sent away. The test was not wrong. It was a snapshot of a moving system, interpreted without the history that gave it meaning.

Changes in bleeding pattern deserve specific attention. Some changes are an expected part of the transition, and others need investigation. Bleeding after menopause, in particular, is always worth assessing rather than assuming.

The evidence on hormone therapy has been revised substantially since the coverage that frightened a generation of women away from it. Current guidance from specialty bodies supports its use for appropriate candidates, with the balance of benefit and risk depending on age, time since menopause, the specific symptoms and personal medical history.

That balance is individual, which is why the honest version of this conversation takes a full appointment. Personal and family history of breast cancer, cardiovascular disease, clotting disorders and liver disease all change the calculation, in both directions.

We will also be straightforward about compounded hormone preparations. The FDA has published specific information about compounding, and compounded products are not subject to the same approval and testing as approved ones. Where an approved product will do the job, that is what we use.

And where hormone therapy is not appropriate, there are other routes. Treating the specific symptom, non-hormonal medication, and addressing sleep and the contributing conditions all have a place. Being told you are not a candidate for one treatment is not the end of the conversation.